| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 124.75× | 124.75× | 143.53× | 112.31× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 3.22× | 2.93× | 3.14× | 6.07× | ||
| 0.52× | 0.52× | 0.44× | 0.44× | ||
| 1.51× | 1.51× | 1.03× | 2.30× | ||
| 0.70× | 0.70× | 0.49× | 1.00× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 112.31 | — | 143.53 | 124.75 | 124.75 | |
| Working Capital Turnover | 6.07 | — | 3.14 | 2.93 | 3.22 | |
| Asset Turnover | 0.44 | — | 0.44 | 0.52 | 0.52 | |
| Cash Conversion (CFO/Net Income) | 2.30 | — | 1.03 | 1.51 | 1.51 | |
| CFO/EBITDA | 1.00 | — | 0.49 | 0.70 | 0.70 |